FDA Adverse Event Other Summary report: N

COAPTITE INJECTABLE IMPLANT

MDR report key: 1890900 · Received October 29, 2010

Report

Report Number
2135225-2010-00073
Event Type
Other
Date Received
October 29, 2010
Date of Event
January 28, 2010
Report Date
October 1, 2010
Manufacturer
MERZ AESTHETICS, INC (FORMERLY BIOFORM MEDICAL, INC)
Product Code
LNM
PMA / PMN Number
P040047
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THIS EVENT WAS REPORTED IN THE LINE LISTING OF THE (B)(4) STUDY STATUS REPORT FOR (B)(4), SUBMITTED TO THE FDA ON 9/30/2010. SINCE THE ADVERSE EVENT REQUIRED CATHETERIZATION TO CORRECT URINARY RETENTION, THIS EVENT WAS DETERMINED TO BE A REPORTABLE EVENT. THE DEVICE HISTORY RECORDS FOR COAPTITE LOT 1014034 WERE REVIEWED; ALL REQUIRED TESTING SPECIFICATIONS HAD BEEN MET PRIOR TO RELEASE, AND THERE WERE NO ABNORMALITIES NOTED. THE SECOND LOT USED ON (B)(6) 2009, AND BOTH SYRINGE LOTS USED FOR THE (B)(6) 2010 INJECTION HAD NOT BEEN RECORDED IN THE PATIENT'S CHART. THE MOST PROBABLE LOT USED WAS REQUESTED BY COAPTITE DISTRIBUTOR, (B)(4).

Description of Event or Problem · 1

(B)(4) STUDY. A PATIENT (B)(4), WAS ENROLLED IN THE (B)(4) STUDY FOR STRESS URINARY INCONTINENCE. THE PATIENT WAS INJECTED TWICE; ON (B)(6) 2009, WITH 3.0ML COAPTITE AND AGAIN ON (B)(6) 2010, WITH 2.0ML OF COAPTITE. THE PATIENT DEVELOPED SEVERE URINARY RETENTION AFTER THE SECOND INJECTION ((B)(6) 2010), WHICH WAS TREATED WITH A FOLEY CATHETER. THE CATHETER WAS REMOVED ON (B)(6) 2010 (5 DAYS POST); SYMPTOMS RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COAPTITE INJECTABLE IMPLANT INJECTABLE IMPLANT LNM MERZ AESTHETICS, INC (FORMERLY BIOFORM MEDICAL, INC) 1014034

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention